Keyphrases
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Sodium-glucose Cotransporter Inhibitors
100%
Cardiac Autonomic Function
100%
Cardioprotection
75%
Sympathetic Nervous System
25%
Antidiabetic Drugs
25%
Autonomic Nervous System
25%
Patients with Diabetes
25%
Heart Failure
25%
Cardiovascular Outcomes
25%
Cardiovascular Outcome Trials
25%
Arrhythmic Risk
25%
Cardiovascular Autonomic Dysfunction
25%
Diabetes Distress
25%
Sudden Arrhythmic Death
25%
Medicine and Dentistry
Cardiovascular System
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Sodium Glucose Cotransporter Inhibitor
100%
Autonomic Function
100%
Clinical Study
50%
Diabetes Mellitus
25%
Autonomic Nervous System
25%
Antidiabetic Agent
25%
Patient with Diabetes
25%
Sympathetic Nervous System
25%
Congestive Heart Failure
25%
Heart Protection
25%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Glucose Cotransporter 2 Inhibitor
100%
Sodium Glucose Cotransporter Inhibitor
100%
Clinical Study
50%
Preclinical Study
50%
Diabetes Mellitus
25%
Antidiabetic Agent
25%
Congestive Heart Failure
25%